Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC.

OBJECTIVES The aim of this study was to investigate early markers of arrhythmic events (AEs) and improve risk stratification in early arrhythmogenic right ventricular cardiomyopathy (ARVC). BACKGROUND AEs are frequent in patients with ARVC, but risk stratification in subjects with early ARVC is challenging. METHODS Early ARVC disease was defined as possible or borderline ARVC diagnosis according to the ARVC Task Force Criteria 2010. We performed resting and signal averaged electrocardiogram (ECG). Using echocardiography, we assessed right ventricular (RV) outflow tract diameter and right ventricular basal diameter (RV diameter). Global longitudinal strain and mechanical dispersion (MD) from strain echocardiography were assessed in both the right and left ventricle. AEs were defined as documented ventricular tachycardia, cardiac syncope, or aborted cardiac arrest. RESULTS Of 162 included subjects with ARVC (41 ± 16 years of age, 47% female), 73 had early ARVC, including mutation positive family members not fulfilling definite ARVC diagnosis. AEs occurred in 15 (21%) subjects with early ARVC. Those with AEs in early disease had larger RV diameter (40 ± 4 mm vs. 37 ± 5 mm), more pronounced RVMD (39 ± 15 ms vs. 26 ± 11 ms), and more pathological signal averaged ECGs compared with those without AEs (all p ≤ 0.05). Adding measurements of RV diameter and RVMD to electrical parameters improved identification of subjects with AEs compared with electrical parameters alone (p = 0.05). CONCLUSIONS ECG parameters, RV diameter, and RVMD were markers of previous arrhythmic events in patients with early ARVC. A combination of electrical and echocardiographic parameters improved identification of subjects with AEs in early ARVC disease.

[1]  T. Chao,et al.  Risk stratification of arrhythmogenic right ventricular cardiomyopathy based on signal averaged electrocardiograms. , 2014, International journal of cardiology.

[2]  Peter Sogaard,et al.  Advanced quantitative echocardiography in arrhythmogenic right ventricular cardiomyopathy. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  T. Edvardsen,et al.  Transmural Differences in Myocardial Contraction in Long-QT Syndrome: Mechanical Consequences of Ion Channel Dysfunction , 2010, Circulation.

[4]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[5]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[6]  N. Wolfe Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: A need to broaden diagnostic criteria , 2005 .

[7]  Pieter A Doevendans,et al.  Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  T. Edvardsen,et al.  Cardiac Mechanical Alterations and Genotype Specific Differences in Subjects With Long QT Syndrome. , 2015, JACC. Cardiovascular imaging.

[9]  Dudley J Pennell,et al.  Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.

[10]  T. Edvardsen,et al.  Imaging assessment of ventricular mechanics , 2011, Heart.

[11]  L. Mestroni,et al.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. , 2011, European heart journal.

[12]  童鸿 Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2011 .

[13]  M. Link,et al.  Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement , 2015, European heart journal.

[14]  M. Link,et al.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.

[15]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[16]  J. Voigt,et al.  Mechanical dispersion assessed by myocardial strain in patients after myocardial infarction for risk prediction of ventricular arrhythmia. , 2010, JACC. Cardiovascular imaging.

[17]  A. Angelini,et al.  Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. , 1999, The American journal of cardiology.

[18]  T. Edvardsen,et al.  Right ventricular mechanical dispersion is related to malignant arrhythmias: a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. , 2011, European heart journal.

[19]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[20]  J. Saffitz Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling. , 2009, Heart rhythm.

[21]  Stefan L. Zimmerman,et al.  Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members , 2015, Circulation. Cardiovascular genetics.

[22]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[23]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.

[24]  T. Edvardsen,et al.  Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.

[25]  J. Svendsen,et al.  Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries , 2015, Scandinavian cardiovascular journal : SCJ.

[26]  R. Hauer,et al.  Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage , 2016, Journal of cardiovascular electrophysiology.

[27]  S. Olsson,et al.  Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia. , 1988, European heart journal.

[28]  R. Hauer,et al.  Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2016, European heart journal.

[29]  Thor Edvardsen,et al.  Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia , 2016, European heart journal cardiovascular Imaging.

[30]  Stefan L. Zimmerman,et al.  Yield of serial evaluation in at-risk family members of patients with ARVD/C. , 2014, Journal of the American College of Cardiology.